Korean AIDS patients and activists calling for compulsory license of Fuzeon

Korea should move a step closer to breaking the drug patent of Fuzeon by asking the Swiss drug giant Roche for the right to copy the product so the country can slash medication costs, according to Korean AIDS patients and civil groups.

Under Korean law, and based on World Trade Organization rules, a nation can break drug patents by applying a "compulsory license" on a product if it is a case...